Cargando…

P366: ARE MINIMAL RESIDUAL DISEASE MEASUREMENTS AFTER CONSOLIDATION THERAPY USEFUL IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA?

Detalles Bibliográficos
Autores principales:	Stutterheim, Janine, Van der Waarden, Rachella, de Groot-Kruseman, Hester, Sonneveld, Edwin, De Haas, Valerie, C Van der Schoot, Ellen, van der Velden, Vincent, Dandis, Rana, Pieters, Rob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428350/ http://dx.doi.org/10.1097/01.HS9.0000968376.07648.d1

Ejemplares similares

Effect of post-consolidation regimen on symptomatic osteonecrosis in three DCOG acute lymphoblastic leukemia protocols
por: van Atteveld, Jenneke E., et al.
Publicado: (2021)

Tyrosine kinase fusion genes in pediatric BCR-ABL1-like acute lymphoblastic leukemia
por: Boer, Judith M., et al.
Publicado: (2016)

Progress against childhood and adolescent acute lymphoblastic leukaemia in the Netherlands, 1990–2015
por: Reedijk, Ardine M. J., et al.
Publicado: (2020)

Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: Risk factors and effect on prognosis
por: Klaassen, Irene L. M., et al.
Publicado: (2019)

S112: THE EFFECT OF IMMUNOGLOBULIN PROPHYLAXIS ON INFECTIOUS MORBIDITY IN PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: RESULTS OF A RANDOMIZED CONTROLLED TRIAL
por: Thus, Kirsten, et al.
Publicado: (2023)

Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia
por: Steeghs, Elisabeth M. P., et al.
Publicado: (2019)

Upfront Treatment Influences the Composition of Genetic Alterations in Relapsed Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
por: Yu, Jiangyan, et al.
Publicado: (2020)

High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia
por: Steeghs, Elisabeth M. P., et al.
Publicado: (2018)

High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma Cohort
por: Kroeze, Emma, et al.
Publicado: (2021)

Is asparaginase encapsulated in erythrocytes effective as second‐line treatment in acute lymphoblastic leukaemia?
por: van der Sluis, Inge M., et al.
Publicado: (2022)

366 soles.
Publicado: (1980)

JAK2 aberrations in childhood B-cell precursor acute lymphoblastic leukemia
por: Steeghs, Elisabeth M.P., et al.
Publicado: (2017)

Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol
por: Stutterheim, Janine, et al.
Publicado: (2021)

Idomeneo KV 366
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1979)

366 Detroit City Mass Vaccination Site Template
por: Leamon, A., et al.
Publicado: (2021)

Minimal residual disease (MRD) detection in acute lymphoblastic leukaemia based on fusion genes and genomic deletions: towards MRD for all
por: Kuiper, Roland P., et al.
Publicado: (2021)

Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia
por: Wojtuszkiewicz, Anna, et al.
Publicado: (2015)

ABL-class Genomic Breakpoint Q-PCR: A Patient-specific Approach for MRD Monitoring in Acute Lymphoblastic Leukemia
por: van Outersterp, Inge, et al.
Publicado: (2023)

Unravelling the Sequential Interplay of Mutational Mechanisms during Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia
por: Antić, Željko, et al.
Publicado: (2021)

Effect of Treatment in a Specialized Pediatric Hemato-Oncology Setting on 5-Year Survival in Acute Lymphoblastic Leukemia: A Quasi-Experimental Study
por: van der Linde, Margrietha, et al.
Publicado: (2022)

The observer's year: 366 nights in the universe
por: Moore, Patrick, et al.
Publicado: (2005)

The observer’s year: 366 nights of the universe
por: Moore, Patrick
Publicado: (1998)

Multiclonal complexity of pediatric acute lymphoblastic leukemia and the prognostic relevance of subclonal mutations
por: Antić, Željko, et al.
Publicado: (2020)

Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia
por: van der Veer, A, et al.
Publicado: (2014)

Evaluation of Platelet Responses in Transfusion-Related Acute Lung Injury (TRALI)
por: Zeeuw van der Laan, Eveline A.N., et al.
Publicado: (2020)

TME7/366: Borderless Teleradiology with CHILI
por: Engelmann, U, et al.
Publicado: (1999)

SAT-366 Hypercalcemia Due to Castleman’s Disease
por: Khan, Sarah Adil, et al.
Publicado: (2020)

P425: A MULTIDIMENSIONAL AND SPATIAL ANALYSIS REVEALS DISTINCT IMMUNE PHENOTYPES AND SECONDARY LYMPHOID ORGAN-RESEMBLING STRUCTURES IN THE BONE MARROW OF PEDIATRIC ACUTE MYELOID LEUKEMIA
por: Koedijk, Joost, et al.
Publicado: (2023)

Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients
por: Sassen, Sebastiaan D.T., et al.
Publicado: (2017)

RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia
por: Jerchel, I S, et al.
Publicado: (2018)

PHF6 mutations in T-cell acute lymphoblastic leukemia
por: Van Vlierberghe, Pieter, et al.
Publicado: (2010)

Women's attitude towards prenatal screening for red blood cell antibodies, other than RhD
por: Koelewijn, JM, et al.
Publicado: (2008)

Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis
por: Koelewijn, JM, et al.
Publicado: (2009)

Identification of Genes Transcriptionally Responsive to the Loss of MLL Fusions in MLL-Rearranged Acute Lymphoblastic Leukemia
por: van der Linden, Marieke H., et al.
Publicado: (2015)

Recurrent NR3C1 Aberrations at First Diagnosis Relate to Steroid Resistance in Pediatric T-Cell Acute Lymphoblastic Leukemia Patients
por: van der Zwet, Jordy C. G., et al.
Publicado: (2020)

366. Impact of Obesity in Patients With Candida Bloodstream Infections
por: Barber, Katie E, et al.
Publicado: (2018)

Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks
por: van der Gronde, Toon, et al.
Publicado: (2017)

Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study
por: Michels, Naomi, et al.
Publicado: (2021)

Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients
por: Scheijen, Blanca, et al.
Publicado: (2017)

Cell-Free RNA from Plasma in Patients with Neuroblastoma: Exploring the Technical and Clinical Potential
por: Lak, Nathalie S. M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8sbh84t1r3uaup2ipqg7013dan